Calcium, Bioenergetics, and Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 404 of the 407 references it cites were found in a registry or an index.
Abstract
Degeneration of substantia nigra (SN) dopaminergic (DAergic) neurons is responsible for the core motor deficits of Parkinson’s disease (PD). These neurons are autonomous pacemakers that have large cytosolic Ca2+ oscillations that have been linked to basal mitochondrial oxidant stress and turnover. This review explores the origin of Ca2+ oscillations and their role in the control of mitochondrial respiration, bioenergetics, and mitochondrial oxidant stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Effects of Ca2+ on mitochondrial bioenergetic metabolism and reactive oxygen species (ROS) production. The two primary sources of ATP in neurons are glycolysis and mitochondrial OXPHOS. During pacemaking, Ca2+ entry through Cav1 channels, coupled with CICR through RyRs, generates an elevation in [Ca2+]. Elevated [Ca2+] reaching the mitochondria favors the uptake of substrates by the mitochondria by acting on transporters and carriers on the IMM; Ca2+ taken up by mitochondria through the voltage-dependent anion channel (VDAC) and MCUC increases OXPHOS by enhancing the activity of the TCA cycle and by stimulating ATP synthesis by Complex V. The downside of this stimulation is an increase in the generation of ROS.](https://figures.cochat.ai/paper-figures/43417c2546714b5b8fd39a68f718f2a2/calcium-bioenergetics-and-parkinsons-disease-figure-2.jpg)
![Figure 3 Toxic effects of elevated [Ca2+] in SN DAergic neurons. The engagement of Cav1 channels in pacemaking and the release of Ca2+ through RyRs generate elevated cytosolic Ca2+ levels that increase α-synuclein (αSYN) aggregation, directly or through the activation of calpains; Ca2+-activated calpains can also damage several intracellular proteins. Ca2+ and calpain cleavage can increase or dysregulate tyrosine hydroxylase activity and DA production, and DA oxidation can favor the aggregation of αSYN.](https://figures.cochat.ai/paper-figures/f8532e4531ef46f7b8724d464c53bf55/calcium-bioenergetics-and-parkinsons-disease-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dopaminergic neurons are more vulnerable to the age-related loss of mitochondrial function, resulting in bioenergetic stress due to their highly ramified processes that harbour dense mitochondria to sustain energy-requiring processes at distal sites.188”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [188]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Calcium signalling: dynamics, homeostasis and remodelling
Berridge, M. J., Bootman, M. D., & Roderick, H. L. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1155 · Cited by 5,585
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Clapham, D. E. (2007) · Cell · doi:10.1016/j.cell.2007.11.028 · Cited by 4,175
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
Stereotaxic mapping of the monoamine pathways in the rat brain
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb10998.x · Cited by 3,819
Mitochondria: In Sickness and in Health
Nunnari, J., & Suomalainen, A. (2012) · Cell · doi:10.1016/j.cell.2012.02.035 · Cited by 3,479
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D.-F., Gautier, C. A., Shen, J., Cookson, M. R., & Youle, R. J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000298 · Cited by 2,944
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Dorsey, E. R., Elbaz, A., Nichols, E., Abbasi, N., Abd-Allah, F., Abdelalim, A., Adsuar, J. C., Ansha, M. G., Brayne, C., Choi, J.-Y. J., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30295-3 · Cited by 2,816
Mitochondrial TCA cycle metabolites control physiology and disease
Martínez-Reyes, I., & Chandel, N. S. (2020) · Nature Communications · doi:10.1038/s41467-019-13668-3 · Cited by 2,813
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Structure and function of the brain serotonin system
Jacobs, B. L., & Azmitia, E. C. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.1.165 · Cited by 2,576
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., & Sheu, S.-S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2004 · Cited by 2,575 · cited 1×
“ATP synthase (complex V) then uses the H+ electrochemical gradient to convert ADP to ATP [50,55,56] (Figure 2).”
MethodProjected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K. M., Holloway, R. G., Kieburtz, K., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,472
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Close Contacts with the Endoplasmic Reticulum as Determinants of Mitochondrial Ca 2+ Responses
Rizzuto, R., Pinton, P., Carrington, W., Fay, F. S., Fogarty, K. E., Lifshitz, L. M., Tuft, R. A., & Pozzan, T. (1998) · Science · doi:10.1126/science.280.5370.1763 · Cited by 2,257
Berridge, M. J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80510-3 · Cited by 2,188
Aston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter
De Stefani, D., Raffaello, A., Teardo, E., Szabò, I., & Rizzuto, R. (2011) · Nature · doi:10.1038/nature10230 · Cited by 1,915 · cited 10×
“Ca2+ entry into the mitochondrial matrix through MCUC stimulates the generation of reducing equivalents by disinhibiting three key TCA dehydrogenases [62].”
BackgroundInfluentialIntegrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter
Baughman, J. M., Perocchi, F., Girgis, H. S., Plovanich, M., Belcher-Timme, C. A., Sancak, Y., Bao, X. R., Strittmatter, L., Goldberger, O., Bogorad, R. L., et al. (2011) · Nature · doi:10.1038/nature10234 · Cited by 1,906 · cited 10×
“Ca2+ entry into the mitochondrial matrix through MCUC stimulates the generation of reducing equivalents by disinhibiting three key TCA dehydrogenases [62].”
BackgroundInfluentialThe pathways of mitophagy for quality control and clearance of mitochondria
Ashrafi, G., & Schwarz, T. L. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.81 · Cited by 1,900
Mitochondrial form and function
Friedman, J. R., & Nunnari, J. (2014) · Nature · doi:10.1038/nature12985 · Cited by 1,803
Mitochondria as sensors and regulators of calcium signalling
Rizzuto, R., De Stefani, D., Raffaello, A., & Mammucari, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3412 · Cited by 1,781 · cited 2×
“In healthy mitochondria, the electrochemical gradient across the IMM created by the electron transport chain (ETC) is very steep (~180 mV), providing a strong driving force for Ca2+ entry into the mitochondrial matrix [25,26].”
BackgroundKirkwood, T. B. L., & Austad, S. N. (2000) · Nature · doi:10.1038/35041682 · Cited by 1,774
The substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1437 · Cited by 1,756
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Synaptic Energy Use and Supply
Harris, J. J., Jolivet, R., & Attwell, D. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.019 · Cited by 1,747 · cited 1×
“The hundreds of thousands of DA release sites create an independent burden, as the release and recycling of synaptic vesicles is bioenergetically expensive [63,65,68,132].”
BackgroundModulation of Striatal Projection Systems by Dopamine
Gerfen, C. R., & Surmeier, D. J. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113641 · Cited by 1,718
Self-citationMolecular Physiology of Low-Voltage-Activated T-type Calcium Channels
Perez-Reyes, E. (2003) · Physiological Reviews · doi:10.1152/physrev.00018.2002 · Cited by 1,652
The proteostasis network and its decline in ageing
Hipp, M. S., Kasturi, P., & Hartl, F. U. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0101-y · Cited by 1,642
Voltage-Gated Calcium Channels
Catterall, W. A. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003947 · Cited by 1,628 · cited 3×
“For example, in presynaptic regions, Cav2 channels control exocytosis of neurotransmitters [11].”
BackgroundInfluentialBender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570
RESPIRATORY ENZYMES IN OXIDATIVE PHOSPHORYLATION
Chance, B., & Williams, G. R. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57189-7 · Cited by 1,473
Csordás, G., Renken, C., Várnai, P., Walter, L., Weaver, D., Buttle, K. F., Balla, T., Mannella, C. A., & Hajnóczky, G. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200604016 · Cited by 1,373
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301
A Cellular Perspective on Brain Energy Metabolism and Functional Imaging
Magistretti, P. J., & Allaman, I. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.035 · Cited by 1,285 · cited 1×
“OXPHOS complements glycolysis, generating 18 molecules of ATP for each pyruvate molecule produced from the metabolism of glucose [53,54].”
BackgroundMitochondria and neuronal survival
Nicholls, D. G., & Budd, S. L. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.1.315 · Cited by 1,243 · cited 1×
“ATP synthase (complex V) then uses the H+ electrochemical gradient to convert ADP to ATP [50,55,56] (Figure 2).”
MethodMicrodomains of Intracellular Ca2+: Molecular Determinants and Functional Consequences
Rizzuto, R., & Pozzan, T. (2006) · Physiological Reviews · doi:10.1152/physrev.00004.2005 · Cited by 1,206 · cited 2×
“In physiological situations, this concentration is achieved inside neurons only in microdomains where diffusion is restricted [3,31].”
BackgroundRizzuto, R., Brini, M., Murgia, M., & Pozzan, T. (1993) · Science · doi:10.1126/science.8235595 · Cited by 1,205
PINK1 and Parkin Target Miro for Phosphorylation and Degradation to Arrest Mitochondrial Motility
Wang, X., Winter, D., Ashrafi, G., Schlehe, J., Wong, Y. L., Selkoe, D., Rice, S., Steen, J., LaVoie, M. J., & Schwarz, T. L. (2011) · Cell · doi:10.1016/j.cell.2011.10.018 · Cited by 1,171
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116 · cited 8×
“It has become increasingly clear that other transmitter phenotypes, particularly cholinergic and adrenergic neurons, also are highly vulnerable in PD [8,72].”
BackgroundInfluentialSelf-citationEmmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S. D., Ntzouni, M., Margaritis, L. H., Stefanis, L., & Vekrellis, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5699-09.2010 · Cited by 1,115
Endoplasmic reticulum-mitochondria contacts: Function of the junction
Rowland, A. A., & Voeltz, G. K. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3440 · Cited by 1,018
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
Shin, J.-H., Ko, H. S., Kang, H., Lee, Y., Lee, Y.-I., Pletinkova, O., Troconso, J. C., Dawson, V. L., & Dawson, T. M. (2011) · Cell · doi:10.1016/j.cell.2011.02.010 · Cited by 953
The machineries, regulation and cellular functions of mitochondrial calcium
Giorgi, C., Marchi, S., & Pinton, P. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0052-8 · Cited by 941
Grace, A. A., & Bunney, B. S. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90135-5 · Cited by 934
‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C., Tkatch, T., Meredith, G. E., & Surmeier, D. J. (2007) · Nature · doi:10.1038/nature05865 · Cited by 904
Self-citationDorsal raphe neurons: depression of firing during sleep in cats
McGinty, D. J., & Harper, R. M. (1976) · Brain Research · doi:10.1016/0006-8993(76)90480-7 · Cited by 900
Kraytsberg, Y., Kudryavtseva, E., McKee, A. C., Geula, C., Kowall, N. W., & Khrapko, K. (2006) · Nature Genetics · doi:10.1038/ng1778 · Cited by 887
Regulation of mitochondrial dehydrogenases by calcium ions
Denton, R. M. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.01.005 · Cited by 881 · cited 1×
“Ca2+ entry into the mitochondrial matrix through MCUC stimulates the generation of reducing equivalents by disinhibiting three key TCA dehydrogenases [62].”
BackgroundDopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
Burbulla, L. F., Song, P., Mazzulli, J. R., Zampese, E., Wong, Y. C., Jeon, S., Santos, D. P., Blanz, J., Obermaier, C. D., Strojny, C., et al. (2017) · Science · doi:10.1126/science.aam9080 · Cited by 874
Self-citationMatsuda, W., Furuta, T., Nakamura, K. C., Hioki, H., Fujiyama, F., Arai, R., & Kaneko, T. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4029-08.2009 · Cited by 865
Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study
Jones, B. E., & Moore, R. Y. (1977) · Brain Research · doi:10.1016/0006-8993(77)90378-x · Cited by 864
Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859 · cited 1×
“These neurons—whose degeneration is responsible for the core motor symptoms of Parkinson’s disease (PD) [6,7]—have large cytosolic oscillations in Ca2+ concentration ([Ca2+]).”
BackgroundSelf-citationFoote, S. L., Aston-Jones, G., & Bloom, F. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.3033 · Cited by 857
Mitochondria and neuronal activity
Kann, O., & Kovács, R. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00222.2006 · Cited by 855 · cited 1×
“ATP synthase (complex V) then uses the H+ electrochemical gradient to convert ADP to ATP [50,55,56] (Figure 2).”
MethodOxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
Guzman, J. N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schumacker, P. T., & Surmeier, D. J. (2010) · Nature · doi:10.1038/nature09536 · Cited by 843
Self-citationVerstreken, P., Ly, C. V., Venken, K. J. T., Koh, T.-W., Zhou, Y., & Bellen, H. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.018 · Cited by 841
Activity-driven local ATP synthesis is required for synaptic function
Rangaraju, V., Calloway, N., & Ryan, T. A. (2014) · Cell · doi:10.1016/j.cell.2013.12.042 · Cited by 836 · cited 1×
“The hundreds of thousands of DA release sites create an independent burden, as the release and recycling of synaptic vesicles is bioenergetically expensive [63,65,68,132].”
BackgroundGenetic Animal Models of Parkinson's Disease
Dawson, T. M., Ko, H. S., & Dawson, V. L. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.034 · Cited by 823
Intracellular Ca2+ Sensing: Its Role in Calcium Homeostasis and Signaling
Bagur, R., & Hajnóczky, G. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.028 · Cited by 815 · cited 1×
“As a consequence, a sophisticated collection of molecular mechanisms exists to achieve this end [1,3,15,16].”
BackgroundRaphe unit activity in freely moving cats: Correlation with level of behavioral arousal
Trulson, M. E., & Jacobs, B. L. (1979) · Brain Research · doi:10.1016/0006-8993(79)90157-4 · Cited by 811
MAM: more than just a housekeeper
Hayashi, T., Rizzuto, R., Hajnoczky, G., & Su, T.-P. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.12.002 · Cited by 787
NCLX is an essential component of mitochondrial Na+/Ca2+exchange
Palty, R., Silverman, W. F., Hershfinkel, M., Caporale, T., Sensi, S. L., Parnis, J., Nolte, C., Fishman, D., Shoshan-Barmatz, V., Herrmann, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908099107 · Cited by 787 · cited 1×
“Ca2+ is extruded from mitochondria by a Ca2+/H+ exchanger and—particularly in excitable cells—a Na+/Ca2+ exchanger (or Na+/Ca2+/Li2+ exchanger, NCLX) [25,42,43].”
BackgroundLardy, H. A., & Wellman, H. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50892-4 · Cited by 774
Where Does Parkinson Disease Pathology Begin in the Brain?
Del Tredici, K., Rüb, U., de Vos, R. A. I., Bohl, J. R. E., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.413 · Cited by 773
Axonal transport deficits and neurodegenerative diseases
Millecamps, S., & Julien, J.-P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3380 · Cited by 755
Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface
Csordás, G., Várnai, P., Golenár, T., Roy, S., Purkins, G., Schneider, T. G., Balla, T., & Hajnóczky, G. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.029 · Cited by 750
Neuronal calcium signaling: function and dysfunction
Brini, M., Calì, T., Ottolini, D., & Carafoli, E. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1550-7 · Cited by 748 · cited 3×
“, metabotropic glutamate receptors) that do not flux Ca2+ themselves but generate ligands for receptors that release Ca2+ from intracellular stores [12,13].”
BackgroundKeeney, P. M., Xie, J., Capaldi, R. A., & Bennett, J. P. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0984-06.2006 · Cited by 747
McLelland, G., Soubannier, V., Chen, C. X., McBride, H. M., & Fon, E. A. (2014) · The EMBO Journal · doi:10.1002/embj.201385902 · Cited by 743
The human raphe nuclei and the serotonergic system
Hornung, J.-P. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.002 · Cited by 742
Role of Axonal Transport in Neurodegenerative Diseases
De Vos, K. J., Grierson, A. J., Ackerley, S., & Miller, C. C. J. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.061307.090711 · Cited by 738
Deciphering the Molecular Signals of PINK1/Parkin Mitophagy
Nguyen, T. N., Padman, B. S., & Lazarou, M. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.05.008 · Cited by 732
Grace, A., & Onn, S. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-10-03463.1989 · Cited by 718
Braak, H., Del Tredici, K., Bratzke, H., Hamm-Clement, J., Sandmann-Keil, D., & Rüb, U. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1301-4 · Cited by 708
Axonal transport: cargo-specific mechanisms of motility and regulation
Maday, S., Twelvetrees, A. E., Moughamian, A. J., & Holzbaur, E. L. F. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.019 · Cited by 683
Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D. S., Tabrizi, S. J., Wood, N. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.013 · Cited by 682
Schapira, A. H. V., Mann, V. M., Cooper, J. M., Dexter, D., Daniel, S. E., Jenner, P., Clark, J. B., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05809.x · Cited by 673
Release of dopamine from dendrites in rat substantia nigra
GEFFEN, L. B., JESSELL, T. M., CUELLO, A. C., & IVERSEN, L. L. (1976) · Nature · doi:10.1038/260258a0 · Cited by 650
Endoplasmic reticulum-mitochondrial contactology: structure and signaling functions
Csordás, G., Weaver, D., & Hajnóczky, G. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.009 · Cited by 625
Mitochondria at the neuronal presynapse in health and disease
Devine, M. J., & Kittler, J. T. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.170 · Cited by 615
Snow, B. J., Rolfe, F. L., Lockhart, M. M., Frampton, C. M., O'Sullivan, J. D., Fung, V., Smith, R. A. J., Murphy, M. P., Taylor, K. M., & On behalf of the Protect Study Group (2010) · Movement Disorders · doi:10.1002/mds.23148 · Cited by 606
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons
Ekstrand, M. I., Terzioglu, M., Galter, D., Zhu, S., Hofstetter, C., Lindqvist, E., Thams, S., Bergstrand, A., Hansson, F. S., Trifunovic, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605208103 · Cited by 605
Parkinson's disease: Mechanisms, translational models and management strategies
Raza, C., Anjum, R., & Shakeel, N. U. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.057 · Cited by 603 · cited 2×
“The degeneration of SN DAergic neurons distorts cellular and network activity in the basal ganglia, resulting in the core motor symptoms of PD [6,71,72].”
BackgroundRapid signalling in distinct dopaminergic axons during locomotion and reward
Howe, M. W., & Dombeck, D. A. (2016) · Nature · doi:10.1038/nature18942 · Cited by 602
ΔΨ m ‐Dependent and ‐independent production of reactive oxygen species by rat brain mitochondria
Votyakova, T. V., & Reynolds, I. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00548.x · Cited by 601
Understanding Dopaminergic Cell Death Pathways in Parkinson Disease
Michel, P. P., Hirsch, E. C., & Hunot, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.038 · Cited by 600
Organization of the Locus Coeruleus-Norepinephrine System
Schwarz, L. A., & Luo, L. (2015) · Current Biology · doi:10.1016/j.cub.2015.09.039 · Cited by 578
The substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1421 · Cited by 578
Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
Kawaguchi, Y., Wilson, C., & Emson, P. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03421.1990 · Cited by 565
Hirsch, E. C., Graybiel, A. M., Duyckaerts, C., & Javoy-Agid, F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5976 · Cited by 554
Mitostasis in Neurons: Maintaining Mitochondria in an Extended Cellular Architecture
Misgeld, T., & Schwarz, T. L. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.055 · Cited by 541
Raffaello, A., Mammucari, C., Gherardi, G., & Rizzuto, R. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.001 · Cited by 536
Mosharov, E. V., Larsen, K. E., Kanter, E., Phillips, K. A., Wilson, K., Schmitz, Y., Krantz, D. E., Kobayashi, K., Edwards, R. H., & Sulzer, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.033 · Cited by 534
Pacelli, C., Giguère, N., Bourque, M.-J., Lévesque, M., Slack, R. S., & Trudeau, L.-É. (2015) · Current Biology · doi:10.1016/j.cub.2015.07.050 · Cited by 530
α-Synuclein Is Localized to Mitochondria-Associated ER Membranes
Guardia-Laguarta, C., Area-Gomez, E., Rüb, C., Liu, Y., Magrané, J., Becker, D., Voos, W., Schon, E. A., & Przedborski, S. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2507-13.2014 · Cited by 515
Ludtmann, M. H. R., Angelova, P. R., Horrocks, M. H., Choi, M. L., Rodrigues, M., Baev, A. Y., Berezhnov, A. V., Yao, Z., Little, D., Banushi, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04422-2 · Cited by 513
Protective and toxic roles of dopamine in Parkinson's disease
Segura‐Aguilar, J., Paris, I., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 498
Apoptosis driven by IP3-linked mitochondrial calcium signals
Szalai, G., Krishnamurthy, R., & Hajnóczky, G. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6349 · Cited by 491 · cited 1×
“is the mitochondria permeability transition pore (mPTP), which is generally thought to open only in pathological situations when matrix [Ca2+] gets too high [48]; however, the mPTP can also open transiently to modulate mitochondrial Ca2+ levels [26,49–51].”
BackgroundCalcium, mitochondria and cell metabolism: A functional triangle in bioenergetics
Rossi, A., Pizzo, P., & Filadi, R. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.10.016 · Cited by 489
A Guide to Neurotoxic Animal Models of Parkinson's Disease
Tieu, K. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009316 · Cited by 483
Wang, H., & Morales, M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06576.x · Cited by 477
α1D (Cav1.3) Subunits Can Form L-type Ca2+ Channels Activating at Negative Voltages
Koschak, A., Reimer, D., Huber, I., Grabner, M., Glossmann, H., Engel, J., & Striessnig, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101469200 · Cited by 453
Hall, C. N., Klein-Flugge, M. C., Howarth, C., & Attwell, D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0026-12.2012 · Cited by 451
Yamada, T., McGeer, P. L., Baimbridge, K. G., & McGeer, E. G. (1990) · Brain Research · doi:10.1016/0006-8993(90)91236-a · Cited by 448
Regulation of oxidative phosphorylation in the mammalian cell
Balaban, R. S. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.258.3.c377 · Cited by 446
Agarwal, A., Wu, P.-H., Hughes, E. G., Fukaya, M., Tischfield, M. A., Langseth, A. J., Wirtz, D., & Bergles, D. E. (2017) · Neuron · doi:10.1016/j.neuron.2016.12.034 · Cited by 441
There's Something Wrong with my MAM; the ER–Mitochondria Axis and Neurodegenerative Diseases
Paillusson, S., Stoica, R., Gomez-Suaga, P., Lau, D. H. W., Mueller, S., Miller, T., & Miller, C. C. J. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.01.008 · Cited by 439
Living on the edge with too many mouths to feed: Why dopamine neurons die
Bolam, J. P., & Pissadaki, E. K. (2012) · Movement Disorders · doi:10.1002/mds.25135 · Cited by 436
Haas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., & Shults, C. W. (1995) · Annals of Neurology · doi:10.1002/ana.410370604 · Cited by 435
Morais, V. A., Verstreken, P., Roethig, A., Smet, J., Snellinx, A., Vanbrabant, M., Haddad, D., Frezza, C., Mandemakers, W., Vogt‐Weisenhorn, D., et al. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900006 · Cited by 434
L-Type Calcium Channels: The Low Down
Lipscombe, D., Helton, T. D., & Xu, W. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00486.2004 · Cited by 425
Enjoy the Trip: Calcium in Mitochondria Back and Forth
De Stefani, D., Rizzuto, R., & Pozzan, T. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034216 · Cited by 423 · cited 1×
“In physiological situations, this concentration is achieved inside neurons only in microdomains where diffusion is restricted [3,31].”
BackgroundMice with Mitochondrial Complex I Deficiency Develop a Fatal Encephalomyopathy
Kruse, S. E., Watt, W. C., Marcinek, D. J., Kapur, R. P., Schenkman, K. A., & Palmiter, R. D. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.02.004 · Cited by 419
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Giguère, N., Burke Nanni, S., & Trudeau, L.-E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00455 · Cited by 413
Robust Pacemaking in Substantia Nigra Dopaminergic Neurons
Guzman, J. N., Sánchez-Padilla, J., Chan, C. S., & Surmeier, D. J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2519-09.2009 · Cited by 411
Self-citationThe Parkinson Study Group QE3 Investigators, Beal, M. F., Oakes, D., Shoulson, I., Henchcliffe, C., Galpern, W. R., Haas, R., Juncos, J. L., Nutt, J. G., Voss, T. S., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.131 · Cited by 408
Historical Perspective: Models of Parkinson’s Disease
Chia, S. J., Tan, E.-K., & Chao, Y.-X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072464 · Cited by 401
Giacomello, M., Drago, I., Bortolozzi, M., Scorzeto, M., Gianelle, A., Pizzo, P., & Pozzan, T. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.003 · Cited by 399
Neuhoff, H., Neu, A., Liss, B., & Roeper, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01290.2002 · Cited by 398
Schwaller, B. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004051 · Cited by 386 · cited 3×
“proteins also can serve as Ca2+ sensors and effectors by interacting with an extraordinary array of other signaling molecules [14].”
BackgroundInfluentialBrini, M., & Carafoli, E. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004168 · Cited by 382 · cited 1×
“Given their differences in affinity for Ca2+, it is likely that basal cytosolic [Ca2+] is largely governed by the PMCA and the NCX is engaged by activity that pushes local [Ca2+] higher, as during repetitive spiking [17].”
BackgroundLoss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics
Irrcher, I., Aleyasin, H., Seifert, E. L., Hewitt, S. J., Chhabra, S., Phillips, M., Lutz, A. K., Rousseaux, M. W. C., Bevilacqua, L., Jahani-Asl, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq288 · Cited by 382
A Quantitative Study on the Nigro‐Neostriatal Dopamine Neuron System in the Rat
Andén, N., Fuxe, K., Hamberoer, B., & Hökfelt, T. (1966) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1966.tb03317.x · Cited by 379
Mitochondrial calcium as a key regulator of mitochondrial ATP production in mammalian cells
Griffiths, E. J., & Rutter, G. A. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.01.019 · Cited by 379 · cited 1×
“The mitochondrial matrix Ca2+ stimulates complex V [57].”
BackgroundLiu, S., Sawada, T., Lee, S., Yu, W., Silverio, G., Alapatt, P., Millan, I., Shen, A., Saxton, W., Kanao, T., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002537 · Cited by 371
The molecular era of the mitochondrial calcium uniporter
Kamer, K. J., & Mootha, V. K. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4039 · Cited by 365 · cited 1×
“The MCUC is composed of the channel-forming unit, known as the mitochondrial Ca2+ uniporter (MCU) [27,28], and several accessory proteins that influence MCU gating [29,30].”
BackgroundPaillusson, S., Gomez-Suaga, P., Stoica, R., Little, D., Gissen, P., Devine, M. J., Noble, W., Hanger, D. P., & Miller, C. C. J. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1704-z · Cited by 360
The role of mitochondrial ROS in the aging brain
Stefanatos, R., & Sanz, A. (2018) · FEBS Letters · doi:10.1002/1873-3468.12902 · Cited by 358
Pissadaki, E. K., & Bolam, J. P. (2013) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2013.00013 · Cited by 348
Dautan, D., Huerta-Ocampo, I., Witten, I. B., Deisseroth, K., Bolam, J. P., Gerdjikov, T., & Mena-Segovia, J. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5071-13.2014 · Cited by 343
Elfawy, H. A., & Das, B. (2019) · Life Sciences · doi:10.1016/j.lfs.2018.12.029 · Cited by 343 · cited 1×
“It is important to mention that mtDNA encodes only 13 proteins, all critical components of the OXPHOS machinery; thus, once a cell accumulates enough mtDNA deletions, the ability of mitochondria to produce ATP will be compromised [24,227].”
BackgroundMembrane properties of rat locus coeruleus neurones
Williams, J. T., North, R. A., Shefner, S. A., Nishi, S., & Egan, T. M. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90265-3 · Cited by 341
Mitochondrial function and morphology are impaired in parkin‐mutant fibroblasts
Mortiboys, H., Thomas, K. J., Koopman, W. J. H., Klaffke, S., Abou‐Sleiman, P., Olpin, S., Wood, N. W., Willems, P. H. G. M., Smeitink, J. A. M., Cookson, M. R., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21492 · Cited by 341
Protecting the mitochondrial powerhouse
Scheibye-Knudsen, M., Fang, E. F., Croteau, D. L., Wilson, D. M., & Bohr, V. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.002 · Cited by 334
Puopolo, M., Raviola, E., & Bean, B. P. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4341-06.2007 · Cited by 319 · cited 1×
“However, the opening of Cav1 channels is not necessary for pacemaking, as asserted previously based upon experiments that employed dihydropyridines (DHPs) at concentrations where channel specificity is lost [89,96].”
BackgroundFlirting in Little Space: The ER/Mitochondria Ca 2+ Liaison
Rizzuto, R., Duchen, M. R., & Pozzan, T. (2004) · Science's STKE · doi:10.1126/stke.2152004re1 · Cited by 319
GERMAN, D. C., MANAYE, K. F., SONSALLA, P. K., & BROOKS, B. A. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb24523.x · Cited by 318
Lavoie, B., & Parent, A. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903440204 · Cited by 318
Mitochondrial reactive oxygen species production and elimination
Nickel, A., Kohlhaas, M., & Maack, C. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.03.011 · Cited by 317
Alterations in axonal transport motor proteins in sporadic and experimental Parkinson’s disease
Chu, Y., Morfini, G. A., Langhamer, L. B., He, Y., Brady, S. T., & Kordower, J. H. (2012) · Brain · doi:10.1093/brain/aws133 · Cited by 315
Neuronal vulnerability, pathogenesis, and Parkinson's disease
Sulzer, D., & Surmeier, D. J. (2013) · Movement Disorders · doi:10.1002/mds.25095 · Cited by 315 · cited 6×
“It has become increasingly clear that other transmitter phenotypes, particularly cholinergic and adrenergic neurons, also are highly vulnerable in PD [8,72].”
InfluentialSelf-citationCalì, T., Ottolini, D., Negro, A., & Brini, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.302794 · Cited by 312
The Role of Mitochondrially Derived ATP in Synaptic Vesicle Recycling
Pathak, D., Shields, L. Y., Mendelsohn, B. A., Haddad, D., Lin, W., Gerencser, A. A., Kim, H., Brand, M. D., Edwards, R. H., & Nakamura, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.656405 · Cited by 311 · cited 1×
“The hundreds of thousands of DA release sites create an independent burden, as the release and recycling of synaptic vesicles is bioenergetically expensive [63,65,68,132].”
BackgroundWalking the walk: how kinesin and dynein coordinate their steps
Gennerich, A., & Vale, R. D. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.12.002 · Cited by 306
Muzerelle, A., Scotto-Lomassese, S., Bernard, J. F., Soiza-Reilly, M., & Gaspar, P. (2016) · Brain Structure and Function · doi:10.1007/s00429-014-0924-4 · Cited by 303
Greaves, L. C., Reeve, A. K., Taylor, R. W., & Turnbull, D. M. (2012) · The Journal of Pathology · doi:10.1002/path.3028 · Cited by 302
K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons
Liss, B., Haeckel, O., Wildmann, J., Miki, T., Seino, S., & Roeper, J. (2005) · Nature Neuroscience · doi:10.1038/nn1570 · Cited by 299
Liu, Y., Ma, X., Fujioka, H., Liu, J., Chen, S., & Zhu, X. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906565116 · Cited by 294
Calcium-induced calcium release in neurones
Verkhratsky, A., & Shmigol, A. (1996) · Cell Calcium · doi:10.1016/s0143-4160(96)90009-3 · Cited by 293
Calcium Dynamics as a Machine for Decoding Signals
Giorgi, C., Danese, A., Missiroli, S., Patergnani, S., & Pinton, P. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.01.002 · Cited by 281 · cited 1×
“One of the most intriguing features of Ca2+ that has emerged from this effort is its duality: Ca2+ signals are necessary for cellular health, but can also trigger dysfunction and death [5].”
BackgroundArbuthnott, G. W., & Wickens, J. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2006.12.003 · Cited by 274
Crocker, S. J., Smith, P. D., Jackson-Lewis, V., Lamba, W. R., Hayley, S. P., Grimm, E., Callaghan, S. M., Slack, R. S., Melloni, E., Przedborski, S., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04081.2003 · Cited by 274
L‐type calcium channel blockers and Parkinson disease in Denmark
Ritz, B., Rhodes, S. L., Qian, L., Schernhammer, E., Olsen, J. H., & Friis, S. (2010) · Annals of Neurology · doi:10.1002/ana.21937 · Cited by 273
Locus coeruleus: From global projection system to adaptive regulation of behavior
Aston-Jones, G., & Waterhouse, B. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.001 · Cited by 271
Mitochondria–endoplasmic reticulum choreography: structure and signaling dynamics
Pizzo, P., & Pozzan, T. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.07.011 · Cited by 269
Aging and Parkinson's disease: Different sides of the same coin?
Collier, T. J., Kanaan, N. M., & Kordower, J. H. (2017) · Movement Disorders · doi:10.1002/mds.27037 · Cited by 268 · cited 1×
“It’s our thesis that the vulnerability of SN DAergic neurons to aging and PD [85] is in large measure attributable to their distinctive phenotype [86].”
BackgroundToxin Models of Mitochondrial Dysfunction in Parkinson's Disease
Martinez, T. N., & Greenamyre, J. T. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4033 · Cited by 266
Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
Dölle, C., Flønes, I., Nido, G. S., Miletic, H., Osuagwu, N., Kristoffersen, S., Lilleng, P. K., Larsen, J. P., Tysnes, O.-B., Haugarvoll, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms13548 · Cited by 266
Wolfart, J., & Roeper, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03404.2002 · Cited by 265
Khaliq, Z. M., & Bean, B. P. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0143-10.2010 · Cited by 261
Coupled Oscillator Model of the Dopaminergic Neuron of the Substantia Nigra
Wilson, C. J., & Callaway, J. C. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.5.3084 · Cited by 260
The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease
Ilijic, E., Guzman, J. N., & Surmeier, D. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.04.007 · Cited by 259
Self-citationYung, W. H., Häusser, M. A., & Jack, J. J. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018571 · Cited by 251 · cited 1×
“Consistent with these properties, Cav1 channels drive a slow oscillatory potential (SOPs) in SN DAergic neurons when Na+ channels are blocked with tetrodotoxin [93,95,101,102,107,119,120].”
BackgroundComplex I, iron, and ferritin in Parkinson's disease substantia nigra
Mann, V. M., Cooper, J. M., Daniel, S. E., Srai, K., Jenner, P., Marsden, C. D., & Schapira, A. H. V. (1994) · Annals of Neurology · doi:10.1002/ana.410360612 · Cited by 251
Mitochondria-associated membranes in aging and senescence: structure, function, and dynamics
Janikiewicz, J., Szymański, J., Malinska, D., Patalas-Krawczyk, P., Michalska, B., Duszyński, J., Giorgi, C., Bonora, M., Dobrzyn, A., & Wieckowski, M. R. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0105-5 · Cited by 248
Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
Burke, W. J., Kumar, V. B., Pandey, N., Panneton, W. M., Gan, Q., Franko, M. W., O’Dell, M., Li, S. W., Pan, Y., Chung, H. D., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0303-9 · Cited by 243
Calpain-Cleavage of α-Synuclein
Dufty, B. M., Warner, L. R., Hou, S. T., Jiang, S. X., Gomez-Isla, T., Leenhouts, K. M., Oxford, J. T., Feany, M. B., Masliah, E., & Rohn, T. T. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061232 · Cited by 241
Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations
Müftüoglu, M., Elibol, B., Dalmızrak, Ö., Ercan, A., Kulaksız, G., Ögüs, H., Dalkara, T., & Özer, N. (2004) · Movement Disorders · doi:10.1002/mds.10695 · Cited by 237
Choi, W.-S., Kruse, S. E., Palmiter, R. D., & Xia, Z. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807581105 · Cited by 236
Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease
Surmeier, D. J., & Schumacker, P. T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.410530 · Cited by 236
Self-citationLee, K.-S., Huh, S., Lee, S., Wu, Z., Kim, A.-K., Kang, H.-Y., & Lu, B. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721136115 · Cited by 232
Use of antihypertensives and the risk of Parkinson disease
Becker, C., Jick, S. S., & Meier, C. R. (2008) · Neurology · doi:10.1212/01.wnl.0000303818.38960.44 · Cited by 230
Ashrafi, G., de Juan-Sanz, J., Farrell, R. J., & Ryan, T. A. (2020) · Neuron · doi:10.1016/j.neuron.2019.11.020 · Cited by 230
Loss of Mitochondrial Fission Depletes Axonal Mitochondria in Midbrain Dopamine Neurons
Berthet, A., Margolis, E. B., Zhang, J., Hsieh, I., Zhang, J., Hnasko, T. S., Ahmad, J., Edwards, R. H., Sesaki, H., Huang, E. J., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0930-14.2014 · Cited by 229
Mitochondrial DNA Depletion in Respiratory Chain–Deficient Parkinson Disease Neurons
Grünewald, A., Rygiel, K. A., Hepplewhite, P. D., Morris, C. M., Picard, M., & Turnbull, D. M. (2016) · Annals of Neurology · doi:10.1002/ana.24571 · Cited by 229
Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease
Surmeier, D. J., Guzman, J. N., & Sanchez-Padilla, J. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.003 · Cited by 222
Self-citationThe Interplay of Axonal Energy Homeostasis and Mitochondrial Trafficking and Anchoring
Sheng, Z.-H. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.01.005 · Cited by 221
Parkinson’s disease as a result of aging
Rodriguez, M., Rodriguez‐Sabate, C., Morales, I., Sanchez, A., & Sabate, M. (2015) · Aging Cell · doi:10.1111/acel.12312 · Cited by 214
Travagli, R. A., Gillis, R. A., Rossiter, C. D., & Vicini, S. (1991) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1991.260.3.g531 · Cited by 213
The dorsal raphe nucleus—From silver stainings to a role in depression
Michelsen, K. A., Schmitz, C., & Steinbusch, H. W. M. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.01.002 · Cited by 213
Dryanovski, D. I., Guzman, J. N., Xie, Z., Galteri, D. J., Volpicelli-Daley, L. A., Lee, V. M. Y., Miller, R. J., Schumacker, P. T., & Surmeier, D. J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5311-12.2013 · Cited by 212
Self-citationNedergaard, S., Flatman, J. A., & Engberg, I. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019742 · Cited by 211 · cited 1×
“Consistent with these properties, Cav1 channels drive a slow oscillatory potential (SOPs) in SN DAergic neurons when Na+ channels are blocked with tetrodotoxin [93,95,101,102,107,119,120].”
BackgroundWu, Y., Richard, S., & Parent, A. (2000) · Neuroscience Research · doi:10.1016/s0168-0102(00)00140-1 · Cited by 210
Wang, X., Petrie, T. G., Liu, Y., Liu, J., Fujioka, H., & Zhu, X. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07734.x · Cited by 207
Kieburtz, K., Tilley, B. C., Elm, J. J., Babcock, D., Hauser, R., Ross, G. W., Augustine, A. H., Augustine, E. U., Aminoff, M. J., Bodis-Wollner, I. G., et al. (2015) · JAMA · doi:10.1001/jama.2015.120 · Cited by 207
Fallon, J. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-12-01361.1981 · Cited by 206
Cholinergic brainstem neurons modulate cortical gamma activity during slow oscillations
Mena‐Segovia, J., Sims, H. M., Magill, P. J., & Bolam, J. P. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.153874 · Cited by 206
Burke, W. J., Li, S. W., Williams, E. A., Nonneman, R., & Zahm, D. S. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03354-7 · Cited by 206
Gervasoni, D., Darracq, L., Fort, P., Soulière, F., Chouvet, G., & Luppi, P. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00106.x · Cited by 205
Calcium and Parkinson's disease
Surmeier, D. J., Schumacker, P. T., Guzman, J. D., Ilijic, E., Yang, B., & Zampese, E. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.168 · Cited by 202 · cited 1×
“Feedforward ETC stimulation not only results in longer respiratory bouts but also periods of stimulation during which there is little ATP demand and high mitochondrial membrane potential, a situation that is particularly likely to result in superoxide/ROS production [10,220].”
BackgroundSelf-citationOttolini, D., Cali, T., Negro, A., & Brini, M. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt068 · Cited by 201
Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance
Heeman, B., Van den Haute, C., Aelvoet, S.-A., Valsecchi, F., Rodenburg, R. J., Reumers, V., Debyser, Z., Callewaert, G., Koopman, W. J. H., Willems, P. H. G. M., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.078303 · Cited by 198
Research works printed but not linked: 1
- Rizzuto, 2004, Flirting in little space: The ER/mitochondria Ca2+ liaison, Sci. STKE Signal Transduct. Knowl. Environ., 2004, re1
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Mitochondrial Ca2+ Signaling in Health, Disease and Therapy
Modesti, L., Danese, A., Vitto, V. A. M., Ramaccini, D., Aguiari, G., Gafà, R., Lanza, G., Giorgi, C., & Pinton, P. (2021) · Cells · doi:10.3390/cells10061317 · Cited by 130
“Neuronal Ca2+ regulation is extremely important even before the appearance of the pathological characteristics of these diseases [99,102,103].”
BackgroundMachine learning and digital biomarkers can detect early stages of neurodegenerative diseases
Chudzik, A., Śledzianowski, A., & Przybyszewski, A. W. (2024) · Sensors · doi:10.3390/s24051572 · Cited by 122
Ca 2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons
Zampese, E., Wokosin, D. L., González‐Rodríguez, P., Guzmán, J. N., Tkatch, T., Kondapalli, J., Surmeier, W. C., D’Alessandro, K. B., Stefani, D. D., Rizzuto, R., et al. (2022) · Science Advances · doi:10.1126/sciadv.abp8701 · Cited by 104
“Ca 2+ release by the ER can affect mitochondrial OXPHOS in two ways ( 14 , 43 ).”
InfluentialSelf-citationUnraveling Parkinson’s Disease Neurodegeneration: Does Aging Hold the Clues?
Coleman, C., & Martin, I. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223363 · Cited by 76
“Additionally, dopaminergic neurons may be more vulnerable to age-related loss of mitochondrial function and resulting bioenergetic stress due to their highly ramified processes that harbor dense mitochondria to sustain energy-requiring processes at distal sites [22].”
Background
Metadata
- Authors
- Zampese, E., & Surmeier, D. J.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Surmeier, D. James
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-09-08
- Volume
- 9
- Issue
- 9
- Pages
- 2045
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7564460
- OpenAlex
- W3083790931
- Cited by
- 79
- References
- 407
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 13 · 2023: 13 · 2022: 14 · 2021: 15 · 2020: 1
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Neurological Disorders and Stroke (P50NS047085)
- Michael J. Fox Foundation for Parkinson's Research (Surmeier)
- JPB Foundation (Surmeier)
- IDP Foundation (Surmeier)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, calcium oscillations, substantia nigra, dopaminergic neurons, mitochondrial respiration, bioenergetics, neurodegeneration, motor impairment
- MeSH terms
- Calcium, Energy Metabolism, Humans, Parkinson Disease, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.